• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• 제12권sup1호
• /
• pp.72-76
• /
• 2009

Rotavirus infection is the leading cause of severe diarrhea disease in infants and young children worldwide. Rotavirus infects every child at least once by her/his $5^{th}$ birthday. It has been known that single episode of rotavirus infection can protect or alleviate subsequent illness caused by both homotypic and heterotypic rotaviruses. There are two currently licensed rotavirus vaccines. One is human-bovine rotavirus reassortant pentavalent vaccine ($RotaTeq^{TM}$), which contains five reassortant rotavirus (expressing protein G1, G2, G3, G4 and P[8]) and was licensed in Korea for use among infants in 2007. Another is live-attenuated human rotavirus vaccine ($Rotarix^{TM}$) derived from 89-12 strain which represents the most common of the human rotavirus VP7(G1) and VP4(P[8]) antigens. $Rotarix^{TM}$ was licensed in Korea in 2008. Both live oral rotavirus vaccines are efficacious in preventing severe rotavirus gastroenteritis.

• 한국축산식품학회지
• /
• 제27권4호
• /
• pp.538-542
• /
• 2007

본 연구는 kefir로부터 EPS를 분리하여 MA104 세포에 대한 독성과 rotavirus에 대한 저해효과를 확인하기 위하여 수행하였다. Kefir culture 및 grain 파쇄입자에서 Lactobacillus fermentum, Lactobacillus acidophilus, Lactobacillus brevis 등의 유산균과 Candida kefyr, Cryptococcus albidus, Pichia ohmeri 등의 효모가 분리 동정되었다. EPS의 1% 농도에서, MTT assay에 의한 EPS의 rotavirus에 대한 억제효과는 human rotavirus(KU)가 $72.52{\pm}6.48%$, bovine rotavirus(NCDV)가 $36.06{\pm}7.63%$, porcine rotavirus(OSU)가 $81.66{\pm}1.11%$로 나타났으며, EPS의 1/128% 농도에서, human rotavirus(KU)가 $24.98{\pm}4.58%$, bovine rotavirus(NCDV)가 $4.71{\pm}6.16%$, porcine rotavirus(OSU)가 $4.05{\pm}14.90%$로 나타났다. Kefir에서 분리한 EPS는 다양한 혈청형과 유래 동물의 rotavirus 모두에게 억제 효과가 있는 것으로 확인되었다.

• 생약학회지
• /
• 제39권2호
• /
• pp.118-122
• /
• 2008

This study was conducted to evaluate the inhibitory effects of betulinic acid isolated from Ziziphus jujuba on various human rotavirus, such as KU, S2 and YO. The results obtained are summarized as follows: At the concentration of betulinic acid 0.1/2%, all human rotavirus is showed a maximum effect on their growth even though it's evaluated on the in vitro test. The each inhibitory rate of MA-104 cells infected by human rotavirus KU, S2 and YO was 62.1%, 59.7% and 65.2%, respectively, at the concentration of 0.1/2%. The anti-virus activity of betulinic acid was showed as the dose-dependent manner at the used dosages except at the dose of 0.1%.

• KSBB Journal
• /
• 제14권2호
• /
• pp.131-135
• /
• 1999

원숭이 콩팥세포를 T-flask에서 배양할 때 로타바이러스 감염에 미치는 protease, $CaCl_2$. EGTA, po]ybrene 감염배지내에서 pH의 영향과 formaldehyde에 의한 로타바이러스의 inactivation 정도를 조사하였다. 로타바이러스의 증식은 trypsin이나 clostripain과 같은 protease의 첨가에 의해 크게 향상되었다. $CaCl_2$ 농도가 300 mg/ml이거나 pH가 8인 감염배지에서 로타바이러스의 증식은 각각 8 및 10 배 증가하였다 그러나 EGTA 와 polybrene을 감염배지에 첨가하였을 때 바이러스 증식은 감소하였다. Fonnaldehyde는 로타바이러스 inactivation에 유효하였으며 로타바이러스의 농도는 fomrmaldehyde를 처리하였을 때 1 시간 후 약 53-95% 수준으로 감소하였으며 12 시간 후에는 로타바이러스가 98% 이상 inactivation 되었다.

• 대한바이러스학회지
• /
• 제29권2호
• /
• pp.87-97
• /
• 1999

It has long been known that lactoferrin prevents human beings from infection of virus. To prove this activity of lactoferrin, we evaluated the activities of different lactoferrins to an isolate human rotavirus K-21. Bovine lactoferrin inhibited infection of K-21 to MA-104 cell at the concentration of $25.9\;{\mu}M$ whereas bovine hydrolysed lactoferrin prevented rotavirus infection at $103.8\;{\mu}M$. However human lactoferrin prevented infection of K-21 at the concentration of $217.5\;{\mu}M$. These data suggested that lactoferrin activity may be unaffected by the intestinal digestive enzymes and bovine lactoferrin is more active than human lactoferrin with respect to prevention of rotavirus infection.

• 한국미생물학회:학술대회논문집
• /
• 한국미생물학회 2003년도 International Meeting of the Microbiological Society of Korea
• /
• pp.80-81
• /
• 2003

• 한국축산식품학회지
• /
• 제31권1호
• /
• pp.81-85
• /
• 2011

본 연구에서는kefir중의 polysaccharide분획이 HRV의 MA-104세포 감염에 미치는 억제효과를 조사하였다. (1) 추출된 polysaccharide는 DEAE 이온교환 chromatography에서 fraction I의 미결합 분획과 fraction II, III, IV의 결합 분획으로 나뉘어졌다. (2) Polysaccharide fraction II, III, IV는 각각 4.8, 5.3, 1.4 mg/mL의 농도로 첨가했을 때 HRV의 MA-104 세포감염에 대하여 약 97%, 99%, 100%의 억제효과를 나타냈다. 본 연구의 결과를 종합하면 kefir의 다당체가 유아설사변에서 분리한 rotavirus S-2가 MA-104 cell 감염에 97% 이상 억제효과가 있어 동절기 유아의 바이러스성 급성설사 예방에 kefir를 급식하는 것이 바람직하다고 사료된다.

• 한국축산식품학회지
• /
• 제37권1호
• /
• pp.1-9
• /
• 2017

The rotavirus-induced diarrhea of human and animal neonates is a major public health concern worldwide. Until recently, no effective therapy is available to specifically inactivate the rotavirion particles within the gut. Passive immunotherapy by oral administration of chicken egg yolk antibody (IgY) has emerged of late as a fresh alternative strategy to control infectious diseases of the alimentary tract and has been applied in the treatment of diarrhea due to rotavirus infection. The purpose of this concise review is to evaluate evidence on the properties and performance of anti-rotavirus immunoglobulin Y (IgY) for prevention and treatment of rotavirus diarrhea in human and animal neonates. A survey of relevant anti-rotavirus IgY basic studies and clinical trials among neonatal animals (since 1994-2015) and humans (since 1982-2015) have been reviewed and briefly summarized. Our analysis of a number of rotavirus investigations involving animal and human clinical trials revealed that anti-rotavirus IgY significantly reduced the severity of clinical manifestation of diarrhea among IgY-treated subjects relative to a corresponding control or placebo group. The accumulated information as a whole depicts oral IgY to be a safe and efficacious option for treatment of rotavirus diarrhea in neonates. There is however a clear need for more randomized, placebo controlled and double-blind trials with bigger sample size to further solidify and confirm claims of efficacy and safety in controlling diarrhea caused by rotavirus infection especially among human infants with health issues such as low birth weights or compromised immunity in whom it is most needed.

• 대한의생명과학회지
• /
• 제12권3호
• /
• pp.209-215
• /
• 2006

The mutability and frequency of genetic reassortment characteristic of rotavirus and resultant antigenic changes make the rotavirus formidable challenges for control efforts such as the vaccine development. An alternative approach to overcome these difficulties in development of the rotavirus vaccine is to develop effective inhibitors of the virus infection. As an effort to achieve this, effects of glycyrrhetinic acid (GA), which is an active component of glycyrrhizin, on MA-14 cell infection were examined by employing the human rotavirus isolated from Korea, K-21. The data obtained showed that MA-104 cell infection of the K-21 rotavirus was greatly influenced by the presence of both $18{\alpha}-Ga\;and\;18{\beta}-GA$. Both types of GA have inhibited more than 60% of the rotaviral infection at the concentration of 7.68mM. This inhibition effect became much more evident at the higher concentrations of GA. However, the type of GA did not make much differences on the inhibition effect of the drug. Although GA has to be used in high concentrations to exhibit anti-viral activity and to be virostatic, a long history of safe and high dose usage of licoriece in clinical settings in the Far East makes the GA as an attractive inhibitor of the rotaviral infection.

• 생명과학회지
• /
• 제28권4호
• /
• pp.478-482
• /
• 2018

인간 rotavirus는 영아에게 급성 설사를 일으키는 병원체의 하나이다. 본 연구에서는 Escherichia coli의 코돈 선호도를 따라서 인간 rotavirus A (serotype 1 strain WA)의 $VP8^*$ 단백질을 일부분 암호화하도록 인공적인 유전자를 합성하였다. 합성된 $VP8^*$ 유전자는 코돈을 번역틀에 일치시키고 클로닝이 용이하도록 하기 위한 NdeI 및 HindIII 제한효소 절단 부위와 친화적 정제를 위한 6-히스티딘 암호화 서열을 C-말단에 보유하고 있다. 합성된 $VP8^*$ DNA 절편을 pT7-7 발현 벡터에 삽입하여 E. coli BL21 (DE3)로 형질전환한 후에 최종 농도 0.05 mM IPTG로 생산을 유도한 결과 예상했던 대로 19.7-kDa 크기의 $VP8^*$ 단백질이 고농도로 발현되었다. SDS-PAGE에 전개된 단백질들을 대상으로 mouse anti-rotavirus capsid antibody를 사용한 Western blotting의 결과 ~20-kDa $VP8^*$ 단백질 밴드가 관찰되었다. 인공 $Vp8^*$ 단백질이 피하 주사된 토끼의 polyclonal antibody 혈장을 이용한 조사에서도 동일한 크기의 단백질 밴드를 확인할 수 있었다. 이는 합성된 유전자가 바이러스성 질환을 통제할 항원성 백신 후보의 생산 혹은 진단용 항체를 개발하기 위한 쉽고 빠른 방법을 제공할 수 있다는 의미이다.